Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2000
03/09/2000CA2345355A1 Electrically controlled transport of charged penetrants across barriers
03/09/2000CA2342797A1 Preserved cyclodextrin-containing compositions
03/09/2000CA2342209A1 Omeprazole formulation
03/09/2000CA2341596A1 Microparticulate composition
03/09/2000CA2341352A1 Oral vaccine compositions
03/09/2000CA2340975A1 Synthetic tear fluid
03/09/2000CA2340865A1 High-affinity antibodies
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2339823A1 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/09/2000CA2338788A1 Drug delivery device for stent
03/08/2000EP0983769A1 Permucous preparation
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983264A1 Method of manufacturing sertindole
03/08/2000EP0983091A1 Obesity protein formulations
03/08/2000EP0983088A1 Immunopotentiating composition
03/08/2000EP0983087A1 Multivalent vaccine composition with mixed carrier
03/08/2000EP0983086A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
03/08/2000EP0983083A1 Somatotropin compositions mixed with vitamins
03/08/2000EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
03/08/2000EP0983065A1 Gastric-retained pharmaceutical composition
03/08/2000EP0983060A1 Solid porous matrices and methods of making and using the same
03/08/2000EP0983058A1 Medicinal aerosol products
03/08/2000EP0983038A1 Novel powder compositions
03/08/2000EP0983037A1 Antifungal nail lacquer and method using same
03/08/2000EP0982990A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use
03/08/2000EP0982988A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
03/08/2000EP0946621A4 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair
03/08/2000EP0859804B1 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof
03/08/2000EP0820275A4 Cosmetic melanins
03/08/2000EP0684806B1 Transmucosal delivery of macromolecular drugs
03/08/2000CN1246891A Polypeptide-polymer conjugates having added and/or removed attachment groups
03/08/2000CN1246801A Arginine silicate inositol complex and use thereof
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246790A Biocompatible compounds for pharmaceutical drug delivery systems
03/08/2000CN1246369A Tissue humidifying composite and method
03/08/2000CN1246339A Wetting composition and method for vagina tissue
03/08/2000CN1050043C Pharmaceutical granulate
03/07/2000USRE36605 Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, an iodide compound, a peroxide and a surfactant
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034221 Reduced side effects
03/07/2000US6034175 Biopolymer insert
03/07/2000US6034137 Cationic lipids for gene therapy
03/07/2000US6034085 Salt form of nefazodone for use in extended release formulations
03/07/2000US6034073 Solvent detergent emulsions having antiviral activity
03/07/2000US6034054 Solution containing tris buffer, arginine, zinc and preservative
03/07/2000US6034053 Vascular disorders
03/07/2000US6033917 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/07/2000US6033884 Delivering nucleic acid into a cell.
03/07/2000US6033780 Fine particles of petaloid porous hydroxyapatite and process for producing the same
03/07/2000US6033646 Method of preparing fluorinated gas microspheres
03/07/2000US6033644 Biomodulators as universal imaging agents
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011152A1 Streptavidin mutants having secondary functional domains
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000011010A1 Phosphoglycolipid and methods for its use
03/02/2000WO2000011007A1 Carboxylated phosphatidic acid esters
03/02/2000WO2000010962A1 Chromium l-threonate, process for preparation of the same and their use
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010570A1 Aqueous liquid preparations
03/02/2000WO2000010568A1 Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase a¿2?
03/02/2000WO2000010564A1 4-amino-3-mercapto-1,2,4-triazoles
03/02/2000WO2000010559A1 Inorgasmia treatment
03/02/2000WO2000010557A1 Stabilized solid preparations
03/02/2000WO2000010541A1 Stable spray-dried protein formulations
03/02/2000WO2000010540A1 Spray on bandage and drug delivery system
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO2000010534A1 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt
03/02/2000WO2000010531A1 Injectable aqueous dispersions of propofol
03/02/2000WO2000010530A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010527A1 Oral mucoadhesive compositions containing gastrointestinal actives
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO2000010525A2 Fish gelatinous composition for use as an ingredient in tablets
03/02/2000WO2000010506A2 Angiogenesis inhibitors and uses thereof
03/02/2000WO2000010385A1 Method of enhancing catheter patency using a citrate salt catheter lock solution
03/02/2000WO1999065513A3 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
03/02/2000WO1999065506A3 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
03/02/2000WO1999065469A3 Processes to generate submicron particles of water-insoluble compounds
03/02/2000WO1999064059A3 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1999055377A9 Polyol-ifn-beta conjugates
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
03/02/2000DE19847633C1 Preparation of retinol-gamma cyclodextrin complex useful in skin care cosmetic or dermatological compositions comprises using retinol as solution in polysorbate, giving quantitative conversion to stable complex
03/02/2000DE19839276A1 Verfahren zur Herstellung von festen Dosierungsformen A process for the preparation of solid dosage forms
03/02/2000DE19838851A1 Cosmetic agents, especially hair cosmetics, comprise water-soluble or water dispersible polymers which are also useful in pharmaceutical products and coatings for the textile, paper, printing, leather and adhesive industries
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838636A1 Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein A carotenoid formulation comprising a mixture of beta-carotene, lycopene and lutein
03/02/2000CA2664159A1 Carbonyl-stress improving agent and peritoneal dialysate
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2341516A1 Cationic complexes of polymer-modified adenovirus
03/02/2000CA2341485A1 Timed release tablet comprising naproxen and pseudoephedrine
1 ... 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 ... 1712